NTLA – intellia therapeutics, inc. (US:NASDAQ)

Sec Filings

Form S-8 Intellia Therapeutics,
Form 10-K Intellia Therapeutics, For: Dec 31
Form 8-K Intellia Therapeutics, For: Feb 26
Form SCHEDULE 13G/A Intellia Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Form SCHEDULE 13G/A Intellia Therapeutics, Filed by: Contrarius Investment Management Ltd
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com